HLB Life Science Co. Ltd (067630) — Capital Reinvestment Ratio
HLB Life Science Co. Ltd (067630) has a Capital Reinvestment Ratio of 0.99x as of March 2023, meaning it reinvests 1% of its operating cash flow (₩3.55 Billion) in capital expenditures (₩3.52 Billion). Check 067630 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HLB Life Science Co. Ltd Capital Reinvestment Ratio (2012–2020)
This chart tracks HLB Life Science Co. Ltd's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see HLB Life Science Co. Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for HLB Life Science Co. Ltd (2012–2020)
Year-by-year Capital Reinvestment Ratio for HLB Life Science Co. Ltd from 2012 to 2020. See 067630 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 4.18x | ₩2.01 Billion | ₩8.41 Billion | ▲ +18377.9% |
| 2014 | 0.02x | ₩10.43 Billion | ₩236.21 Million | ▲ +29.7% |
| 2013 | 0.02x | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩13.97 Billion | ₩9.18 Billion | — |